160 related articles for article (PubMed ID: 24701478)
1. Profile of yeasts isolated from urinary tracts of catheterized patients.
Mishra M; Agrawal S; Raut S; Kurhade AM; Powar RM
J Clin Diagn Res; 2014 Feb; 8(2):44-6. PubMed ID: 24701478
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Candiduria-Study of Virulence Factors and Its Antifungal Susceptibility Pattern in Tertiary Care Hospital.
Pramodhini S; Srirangaraj S; Easow JM
J Lab Physicians; 2021 Sep; 13(3):231-237. PubMed ID: 34602787
[No Abstract] [Full Text] [Related]
4. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
Aslan H; Gülmez D
Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial candiduria in chronic liver disease patients at a hepatobilliary center.
Rathor N; Khillan V; Sarin SK
Indian J Crit Care Med; 2014 Apr; 18(4):234-7. PubMed ID: 24872653
[TBL] [Abstract][Full Text] [Related]
7. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
8. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of asymptomatic nosocomial candiduria due to
Aghili SR; Abastabar M; Soleimani A; Haghani I; Azizi S
Curr Med Mycol; 2020 Dec; 6(4):1-8. PubMed ID: 34195453
[TBL] [Abstract][Full Text] [Related]
11. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
12. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
13. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
Skrodeniene E; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
[TBL] [Abstract][Full Text] [Related]
14. Antifungal Susceptibility Patterns of Vulvovaginal
Mukasa KJ; Herbert I; Daniel A; Sserunkuma KL; Joel B; Frederick B
Br Microbiol Res J; 2015; 5(4):322-331. PubMed ID: 26594637
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
18. High incidence of azole resistance among
Zarrinfar H; Kord Z; Fata A
Curr Med Mycol; 2021 Sep; 7(3):18-21. PubMed ID: 35528623
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
[TBL] [Abstract][Full Text] [Related]
20. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
Mokaddas EM; Al-Sweih NA; Khan ZU
J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]